Imatinib is a small molecule that inhibits PDGFRA and PDGFRB, as well as the RTKs c-Abl and c-Kit, and is a radiation-sensitising agent for glioma cells in vitro (79) and in orthotopic GBM models in vivo (80, 81). The gene discussed is PDGFRB; the disease is glioblastoma.